BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3780394)

  • 1. [Effect of nifedipine on platelet function].
    Hu ZW
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Jun; 14(3):145-6. PubMed ID: 3780394
    [No Abstract]   [Full Text] [Related]  

  • 2. [A method for determining individual nifedipine sensitivity in treating hypertension patients].
    Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP
    Ter Arkh; 1993; 65(12):19-22. PubMed ID: 8146764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet aggregation in patients with coronary disease treated with nifedipine].
    Tkaczewski W; Goch JH; Kruszyński G; Ryniec A
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):219-21. PubMed ID: 2216944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF; Bareford D; Beevers DG
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of nifedipine on platelet function in normal subjects at rest and during exertion].
    Bonnet J; Hourdille P; Boisseau M; Broustet JP
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II109-13. PubMed ID: 7170401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of nifedipine, a calcium antagonist, on platelet function.
    Dale J; Landmark KH; Myhre E
    Am Heart J; 1983 Jan; 105(1):103-5. PubMed ID: 6849223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
    Kätzel R; Dietzel H; Selle B; Taube C
    Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis.
    Grabowski EF; McDonnell SL; Thomson C; Rodriguez M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S101-2; discussion S107-9. PubMed ID: 1808100
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients.
    Uehara S; Handa H; Hirayama A
    Arzneimittelforschung; 1986 Nov; 36(11):1687-9. PubMed ID: 3814228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of sodium beta-benzalbutyrate on platelet adhesion and aggregation. Study on normal subjects and coronary patients].
    De Marco L; Peruffo R; Virgolini L; Fabris F; Girolami A
    Clin Ter; 1976 Mar; 76(5):419-28. PubMed ID: 1033051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Properties of thrombocytes in patients with ischemic heart disease].
    Sopina NV
    Vrach Delo; 1987 Apr; (4):39-41. PubMed ID: 3617634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of graduated doses of nifedipine on ADP-induced platelet aggregation].
    Campa PP; Di Michele D; Paparoni S; De Curtis G; Fraioli A
    Boll Soc Ital Cardiol; 1980; 25(8):963-4. PubMed ID: 7284187
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris.
    Hiroki T; Inoue T; Yoshida T; Arakawa K
    Arzneimittelforschung; 1982; 32(12):1572-4. PubMed ID: 6891598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary studies of the effect of nifedipine on platelet aggregation induced with ADP].
    Campa PP; Di Michele D; Paparoni S; De Curtis G; Moschetta D
    Boll Soc Ital Cardiol; 1980; 25(3):225-30. PubMed ID: 7284127
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of long-term therapy with a calcium antagonist on thrombocyte function in hypertension patients].
    Baliakina EV; Atakhanov ShE; Gabbasov ZA; Popov EG; Iurenev AP
    Ter Arkh; 1992; 64(8):39-43. PubMed ID: 1440393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiplatelet agents: how much? which one? for whom?].
    Gomes OM
    Arq Bras Cardiol; 1982 Jan; 38(1):1-2. PubMed ID: 7150049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of oral glucose load on blood lipids and on platelet function].
    Carleo R; Miano P; Sgambato F; Cioffi LA
    Boll Soc Ital Biol Sper; 1980 May; 56(9):853-9. PubMed ID: 7448083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.